Newsletter | December 9, 2024

12.09.24 -- Needle-Free Rescue Therapies With Crossject

FEATURED EDITORIAL

Needle-Free Rescue Therapies With Crossject

By Drug Delivery Leader: In Combination

How quickly can emergency treatment for seizures or chronic attacks be delivered? With advances in needle-free autoinjectors, near-immediacy is within reach. Crossjet's CEO Patrick Alexandre and CMO Dan Chiche discuss rapid self-administration and collaborative efforts in drug formulation and device engineering.

Organizational Imperatives For Combination Product Development

By Fran DeGrazio, Drug Delivery Leader

Developers of combination products must address varied and numerous regulatory stipulations and considerations. Drug delivery industry veteran Fran DeGrazio offers recommendations for how to do so efficiently and effectively.

INDUSTRY INSIGHTS

Overcoming Wet Injection Challenges With Human-Centric Design

Article | By Jessica Sanford, Ph.D., Battelle

By understanding the causes of wet injections and employing effective mitigation strategies, we can design safer, more user-friendly, and more effective devices.

Challenges With Pediatric Flavors For Taste Enhancement And Modulation

Webinar | Adare Pharma Solutions

Taste masking for children can present unique challenges for drug developers. Learn how we can use flavor, not just to provide a desired taste, but also to provide taste masking.

Combining Human Needs With High Viscosity Formulations

Article | SMC Ltd.

Review the requirements of designing an autoinjector capable of handling the high pressures necessary for the delivery of highly viscous drug formulations with minimal impact on the patient.

The Flux Performance Of Nanoformed And Untreated PRX Solid Suspensions

Poster | Nanoform

Explore the application of in vitro flux assays to nanoparticles, with data on how the in vitro permeability apparatus can characterize the membrane flux performance of an API formulated as a nanosuspension.

Examining The Emergence Of Unit- And Bi-Dose Nasal Sprays

Q&A | Catalent

Nasal spray administration of medicine offers advantages over oral and IV delivery. Experts discuss the advantages and opportunities of adopting unit- and bi-dose nasal delivery technology.

Prefilled Syringes Market Trends: Improving Patient Experience

Q&A | PCI Pharma Services

Learn how sterile injectable devices are providing safer and more convenient self-injection delivery, leading to positive patient experiences, better therapy adherence, and improved outcomes.

Precision Powder-In-Capsule Micro-Dosing Accelerates Drug Development

White Paper | Lonza

Precision powder microdosing makes it possible to quickly get formulations to the clinic, saving time, money, and use of limited APIs.

SOLUTIONS

Nasal Dosage Form Development

Upperton Pharma Solutions

IV Solution Expansion

B. Braun OEM Division

Enabling The Delivery Of Complex Biologics With Ergonomic Solutions

BD Medical - Pharmaceutical Systems